v3.25.2
FINANCIAL INSTRUMENTS - RISK MANAGEMENT
9 Months Ended
Mar. 31, 2025
FINANCIAL INSTRUMENTS - RISK MANAGEMENT  
FINANCIAL INSTRUMENTS - RISK MANAGEMENT

13.   FINANCIAL INSTRUMENTS – RISK MANAGEMENT

Financial instruments by category

The following tables show additional information required under IFRS 7 on the financial assets and liabilities recorded as of March 31, 2025, and June 30, 2024.

Financial assets by category

Mandatorily measured at fair

Amortized cost

value through profit or loss

Financial asset

    

03/31/2025

    

06/30/2024

    

03/31/2025

    

06/30/2024

Cash and cash equivalents

 

38,456,989

 

44,473,270

 

 

Other financial assets

 

444,530

 

634,553

 

889,393

 

11,695,528

Trade receivables

 

187,509,041

 

207,320,974

 

 

Other receivables (*)

 

14,743,504

 

18,647,862

 

6,952,603

 

Total

 

241,154,064

 

271,076,659

 

7,841,996

 

11,695,528

(*)

Advances expenses and tax balances are not included.

Financial liabilities by category

Mandatorily measured at fair

Amortized cost

value through profit or loss

Financial liability

    

03/31/2025

    

06/30/2024

    

03/31/2025

    

06/30/2024

Trade and other payables

 

125,418,572

 

156,742,677

 

3,181,670

 

11,989,792

Borrowings

 

171,336,694

178,852,080

 

 

Secured notes

85,430,719

80,809,686

Lease liability

16,536,564

11,284,137

Consideration for acquisition

 

1,163,653

 

4,202,401

 

1,110,544

 

2,724,114

Total

 

399,886,202

 

431,890,981

 

4,292,214

 

14,713,906

Financial instruments measured at fair value

Measurement at fair value at 03/31/2025

    

Level 1

    

Level 2

    

Level 3

Financial assets at fair value

Moolec Science S.A. shares

779,100

Other investments

110,293

Other receivables - Joint ventures and associates

6,952,603

Financial liability at fair value

 

 

 

Trade and other payables

    

    

3,181,670

    

Consideration for acquisition

1,110,544

Measurement at fair value at 06/30/2024

    

Level 1

    

Level 2

    

Level 3

Financial assets at fair value

Mutual funds

6,658,805

US Treasury bills

1,993,668

Moolec Science S.A. shares

1,530,375

Other investments

1,512,680

Financial liability at fair value

Trade and other payables

 

 

11,989,792

 

Consideration for acquisition

2,724,114

Estimation of fair value

The fair value of marketable securities, mutual funds and US Treasury Bills is calculated using the market approach using quoted prices in active markets for identical assets. The quoted marked price used for financial assets held by the Group is the current bid price. These instruments are included in level 1.

The Group’s financial liabilities, which were not traded in an active market, were determined using valuation techniques that maximize the use of available market information, and thus rely as little as possible on specific estimates of the entity specific estimates. If all significant inputs required to fair value an instrument are observable, the instruments are included in level 2.

If one or more of the significant inputs is not based on observable market data, the instruments are included in level 3.

The Group’s policy is to recognize transfers between different categories of the fair value hierarchy at the time they occur or when there are changes in the circumstances that cause the transfer. There were no transfers between levels of the fair value hierarchy. There were no changes in economic or business circumstances affecting fair value.

Financial instruments not measured at fair value

The financial instruments not measured at fair value include cash and cash equivalents, trade accounts receivable, other accounts receivable, trade payables and other debts, borrowings, financed payments and convertible notes.

The carrying value of financial instruments not measured at fair value does not differ significantly from their fair value, except for borrowings (Note 5.9).

Management estimates that the carrying value of the financial instruments measured at amortized cost approximates their fair value.

Currency risk

Foreign currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rate. Currency on foreign exchange risk arises when the Group enters into transactions denominated in a currency other than its functional currency.

The table below sets forth our net exposure to currency risk as of March 31, 2025:

Net foreign currency position

    

03/31/2025

Amount expressed in US$

 

18,745,129

Considering only this net currency exposure as of March 31, 2025 if an US Dollar revaluation or depreciation in relation to other foreign currencies with the remaining variables remaining constant, would have a positive or a negative impact on comprehensive income as a result of foreign exchange gains or losses. We estimate that a devaluation or an appreciation of the US Dollar other currencies of 10% during the period ended March 31, 2025 would have resulted in a net pre-tax loss or gain of approximately $1.9 million.